Extavia

Biotechs Find Strength In Numbers In Treating Multiple Sclerosis
Investors Business Daily
Fri, 07/21/17 - 10:25 am
MS
multiple sclerosis
Roche
Celgene
Novartis
Biogen
ozanimod
Gilenya
Ocrevus
Extavia
2013 Should Be Interesting for Multiple Sclerosis Drugs
Motley Fool
Thu, 01/3/13 - 11:39 am
MS
multiple sclerosis
Teva
Copaxone
Rebif
Pfizer
Merck KGaA
Biogen Idec
Avonex
Bayer
Betaseron
Novartis
Extavia
Sanofi
Tysabri
Aubagio
Elan
Gilenya
BG-12
Novartis gets FDA approval for MS drug
Marketwatch
Mon, 08/17/09 - 09:09 am
Novartis
FDA
MS
multiple sclerosis
Extavia